KUχAI Pronounced Koo-kai

Electra — AI algorithm platform for cardiac ablation

Reads the response to pacing, automatically

Tracks cycle length live during ablation

Complex ablation runs on manual signal analysis

Interval measurement, activation matching and channel review are still done by hand — about two of four hours in a complex case.

AF recurs after ablation in 20–40% of patients.1

1 Mayo Clinic, June 2025. Time split is illustrative.

What Electra is built to do

  1. 01

    Automated measurement

    Intervals, beat labels and signal selection.

  2. 02

    Changes over time

    Interval trends across the procedure.

  3. 03

    Reviewable evidence

    Findings linked to the original signals.

In research: estimated signals, lesion and line assessment.

EP recording system

3D mapping system

Electra

Measurements & labels

Selected signals & trends

Estimated signals · lesion & line assessment (research)

Signal path — results return to the workstation's own display

Inside your system, not a replacement for it

Designed to read the signals the lab already records and return results to the workstation display in real time.

Seeking partners for software licensing and joint development.

Discuss integration

Clinical foundation

4,106cases in our research dataset
~15%one-year recurrence after a first AF ablation at a single centerClinical baseline, not an Electra result. n = 1,509.
50%less time on diagnosis and manual analysis in selected complex casesDevelopment target. 2 h → 1 h.

Recurrence: single-center retrospective data (Kaplan–Meier). Time figures are illustrative targets. Electra is investigational software, not cleared by the FDA or any other regulator, and not available for clinical use.

Clinical practice meets AI engineering

  • Hiro Kohjitani, MD, PhD Co-Founder / CEO Kyoto University
  • Shun Nakamura Co-Founder / CTO FormerlyRakuten
  • Akira Yasuda Business Lead FormerlyIBM
  1. Multicenter evaluation discussions underway in Japan.

  2. JETRO J-StarX program at Mayo Clinic.

  3. HRX Live 2026 semifinalist.

Build and validate Electra with us

For equipment partners, clinical teams and investors.

info@kukhai.ai

KUχAI (incorporation in progress) · Kyoto, Japan · Long-term aspiration: zero recurrence.